1. Haug A, Claeson K, Hansen SE, Sömme R, Stenhagen E, Palmstierna H. Fractionation of alginic acid. Acta Chemica Scandinavica 1959;13:601-3. [ DOI:10.3891/acta.chem.scand.13-0601] 2. Jain D, Bar-Shalom D. Alginate drug delivery systems: application in context of pharmaceutical and biomedical research. Drug Dev Ind Pharm 2014;40:1576-84. [ DOI:10.3109/03639045.2014.917657] 3. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Del Rev 2012;64:18-23. [ DOI:10.1016/j.addr.2012.09.010] 4. Belalia F, Djelali N-E. Rheological properties of sodium alginate solutions. Rev Roum Chim 2014;59:135-45. 5. Castilho M, Rodrigues J, Pires I, Gouveia B, Pereira M, Moseke C, et al. Fabrication of individual alginate-TCP scaffolds for bone tissue engineering by means of powder printing. Biofabrication 2015;7:015004. [ DOI:10.1088/1758-5090/7/1/015004] 6. Swioklo S, Constantinescu A, Connon CJ. Alginate-encapsulation for the improved hypothermic preservation of human adipose-derived stem cells. Stem Cells Transl Med 2016;5:339-49. [ DOI:10.5966/sctm.2015-0131] 7. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989;109:429-40. [ DOI:10.1083/jcb.109.1.429] 8. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001;24:483-8. [ DOI:10.2337/diacare.24.3.483] 9. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62:489-96. [ DOI:10.1016/j.joms.2003.12.003] 10. Fréchette J-P, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 2005;84:434-9. [ DOI:10.1177/154405910508400507] 11. Bir SC, Esaki J, Marui A, Yamahara K, Tsubota H, Ikeda T, et al. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse. J Vasc Surg 2009;50:870-9. e2. [ DOI:10.1016/j.jvs.2009.06.016] 12. Moghadam A, Khozani TT, Mafi A, Namavar MR, Dehghani F. Effects of platelet-rich plasma on kidney regeneration in gentamicin-induced nephrotoxicity. J Korean Med Sci 2017;32:13-21. [ DOI:10.3346/jkms.2017.32.1.13] 13. Mafi A, Moghadam A, Moghadam N. Stereological Evaluation of Cell Proliferation following Intrarenal Injection of Platelet-rich Plasma in Gentamicin-treated Rats. Journal of Ardabil University of Medical Sciences 2019;19:418-29. [In Persian] [ DOI:10.29252/jarums.19.4.418] 14. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14:529-35. 15. Anitua E, Prado R, Orive G. Plasma rich in growth factors in dogs: Two sides of the same coin. Dent Res J 2017;14:427. [ DOI:10.4103/1735-3327.218568] 16. Anitua E, Sánchez M, Orive G, Andia I. Delivering growth factors for therapeutics. Trends Pharmacol Sci 2008;29:37-41. [ DOI:10.1016/j.tips.2007.10.010] 17. Mikula K, Skrzypczak D, Ligas B, Witek-Krowiak A. Preparation of hydrogel composites using Ca 2+ and Cu 2+ ions as crosslinking agents. SN Applied Sciences 2019;1:1-15. [ DOI:10.1007/s42452-019-0657-3] 18. Jing Z, Dai X, Xian X, Du X, Liao M, Hong P, et al. Tough, stretchable and compressive alginate-based hydrogels achieved by non-covalent interactions. RSC Advances 2020;10:23592-606. [ DOI:10.1039/D0RA03733H] 19. Filardo G, Perdisa F, Gelinsky M, Despang F, Fini M, Marcacci M, et al. Novel alginate biphasic scaffold for osteochondral regeneration: an in vivo evaluation in rabbit and sheep models. J Mater Sci Mater Med 2018;29:1-13. [ DOI:10.1007/s10856-018-6074-0] 20. Tohamy KM, Mabrouk M, Soliman IE, Beherei HH, Aboelnasr MA. Novel alginate/hydroxyethyl cellulose/hydroxyapatite composite scaffold for bone regeneration: In vitro cell viability and proliferation of human mesenchymal stem cells. Int J Biol Macromol 2018;112:448-60. [ DOI:10.1016/j.ijbiomac.2018.01.181] |
